News
We recently published 10 Shares Explode as Earnings Impress. Veracyte, Inc. (NASDAQ:VCYT) is one of the best-performing ...
Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.
Defense and security solutions provider KRATOS DEFENSE AND SECURITY SOLUTIONS INC (NASDAQ: KTOS) saw a sell-off by ARK, with 36,628 shares sold between the ARKQ and ARKX (NYSE: ARKX) ETFs, valued at ...
(Nasdaq: VCYT), a leading cancer diagnostics company, today announced that three Afirma-related abstracts will be presented at ENDO 2025, the annual meeting of the Endocrine Society, taking place July ...
Biotechnology company Veracyte (VCYT) is set to replace Triumph Group (TGI) in the S&P SmallCap 600 index prior to the market open on Tuesday, July 29.
Veracyte Inc. (NASD: VCYT) will replace Triumph Group Inc. (NYSE: TGI) in the S&P SmallCap 600 effective prior to the opening of trading on Tuesday, July 29. Warburg Pincus LLC and Berkshire Partners ...
It has been about a month since the last earnings report for Veracyte (VCYT). Shares have lost about 13.6% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Veracyte Inc. company and executive profile by Barron's. View the latest VCYT company infomation and executive bios.
Veracyte, Inc. (NASDAQ:VCYT) detracted from the performance of Artisan Small Cap Fund in the previous quarter due to profitability concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results